The Phychem Technologies IPO is a closed SME Bookbuilding offer (Fresh capital only) that opened on 31 August 2026. The Phychem Technologies IPO closed on 2 September 2026, with an issue price of ₹54 per share. The Phychem Technologies IPO has a face value of ₹10 and a lot size of 2,000 shares. The Phychem Technologies IPO is listed on 7 September 2026. The Phychem Technologies IPO allotment was scheduled for 3 September 2026.
On the financial front, the Phychem Technologies IPO reported revenue of ₹57 crore for 31 Mar 2026, compared with ₹51 crore for 31 Mar 2025. The Phychem Technologies IPO PAT was ₹4 crore against ₹3 crore. The Phychem Technologies IPO EBITDA stood at ₹6 crore with a 10.78% margin. The Phychem Technologies IPO net worth as of 31 Mar 2026 was ₹14 crore.
Always verify The Phychem Technologies IPO details and GMP data with the official offer document before investing in the Phychem Technologies IPO.
Financial Summary
Amount in ₹ Crore
Metric
31 Mar 2026
31 Mar 2025
31 Mar 2024
Total Assets
25
21
18
Revenue
57
51
48
PAT
4
3
2
EBITDA
6
4
3
Net Worth
14
10
7
Reserves
6
9
7
Total Borrowing
6
5
6
Phychem Technologies IPO Financials FAQs
Revenue of Phychem Technologies (Amount in ₹ Crore) — 31 Mar 2026: 57; 31 Mar 2025: 51; 31 Mar 2024: 48. Profit after tax (PAT) — 31 Mar 2026: 4; 31 Mar 2025: 3; 31 Mar 2024: 2.
EBITDA of Phychem Technologies (Amount in ₹ Crore) — 31 Mar 2026: 6; 31 Mar 2025: 4; 31 Mar 2024: 3. The EBITDA margin is 10.78%.
Total assets — 31 Mar 2026: 25; 31 Mar 2025: 21; 31 Mar 2024: 18. Net worth — 31 Mar 2026: 14; 31 Mar 2025: 10; 31 Mar 2024: 7. Reserves & surplus — 31 Mar 2026: 6; 31 Mar 2025: 9; 31 Mar 2024: 7. (Amount in ₹ Crore)
Total borrowing of Phychem Technologies (Amount in ₹ Crore) — 31 Mar 2026: 6; 31 Mar 2025: 5; 31 Mar 2024: 6. Debt-to-equity ratio: 0.43.
The financials shown for Phychem Technologies IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
